4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-038431
Director acquired 100 shares (code L)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PATOU GARY Director | 2021-03-17 | Other acquisition | +100 | $19.49 | $1,949 | 100 | I: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| PATOU GARY Director | 2021-06-03 | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…